GeneDx Holdings Corp. (WGS) on GreekSoup https://greeksoup.ai/stocks/us/wgs/ Every dated entry in the public record on GeneDx Holdings Corp.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 GeneDx Holdings Corp.: short interest 6,021,039 shares at the 15 October 2026 settlement, 8.73 days to coverhttps://greeksoup.ai/stocks/us/wgs/short-interest/us:WGS:short-interest:2026-10-15:68cfbaff22Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: short interest 5,626,310 shares at the 30 September 2026 settlement, 5.95 days to coverhttps://greeksoup.ai/stocks/us/wgs/short-interest/us:WGS:short-interest:2026-09-30:24d8fe49baWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Stueland Katherine (CHIEF EXECUTIVE OFFICER) sold 1,648 shares at $94.26 on 16 September 2026, $155,337https://greeksoup.ai/stocks/us/wgs/insiders/us:WGS:insider:2026-09-18:5e896c7c05Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Stueland Katherine (CHIEF EXECUTIVE OFFICER) sold 148 shares at $95.41 on 16 September 2026, $14,120https://greeksoup.ai/stocks/us/wgs/insiders/us:WGS:insider:2026-09-18:bba7513766Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Stueland Katherine (CHIEF EXECUTIVE OFFICER) sold 1,525 shares at $96.90 on 16 September 2026, $147,774https://greeksoup.ai/stocks/us/wgs/insiders/us:WGS:insider:2026-09-18:b574ad1e5aFri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Stueland Katherine (CHIEF EXECUTIVE OFFICER) sold 4,141 shares at $98.27 on 16 September 2026, $406,936https://greeksoup.ai/stocks/us/wgs/insiders/us:WGS:insider:2026-09-18:49e3082a67Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Stueland Katherine (CHIEF EXECUTIVE OFFICER) sold 3,039 shares at $99.00 on 16 September 2026, $300,846https://greeksoup.ai/stocks/us/wgs/insiders/us:WGS:insider:2026-09-18:3f12b768a2Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Feeley Kevin (CHIEF FINANCIAL OFFICER) sold 586 shares at $94.26 on 16 September 2026, $55,235https://greeksoup.ai/stocks/us/wgs/insiders/us:WGS:insider:2026-09-18:b791ab872dFri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Feeley Kevin (CHIEF FINANCIAL OFFICER) sold 52 shares at $95.41 on 16 September 2026, $4,961https://greeksoup.ai/stocks/us/wgs/insiders/us:WGS:insider:2026-09-18:9b60aa826eFri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Feeley Kevin (CHIEF FINANCIAL OFFICER) sold 541 shares at $96.90 on 16 September 2026, $52,423https://greeksoup.ai/stocks/us/wgs/insiders/us:WGS:insider:2026-09-18:db4994a401Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Feeley Kevin (CHIEF FINANCIAL OFFICER) sold 1,470 shares at $98.27 on 16 September 2026, $144,457https://greeksoup.ai/stocks/us/wgs/insiders/us:WGS:insider:2026-09-18:8a341d2f9eFri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Feeley Kevin (CHIEF FINANCIAL OFFICER) sold 1,079 shares at $99.00 on 16 September 2026, $106,816https://greeksoup.ai/stocks/us/wgs/insiders/us:WGS:insider:2026-09-18:f919a51d70Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: short interest 5,884,765 shares at the 15 September 2026 settlement, 12.09 days to coverhttps://greeksoup.ai/stocks/us/wgs/short-interest/us:WGS:short-interest:2026-09-15:debca25d0dTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Stueland Katherine (CHIEF EXECUTIVE OFFICER) sold 3,692 shares at $84.22 on 9 September 2026, $310,932https://greeksoup.ai/stocks/us/wgs/insiders/us:WGS:insider:2026-09-11:b3b6a5039aFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Feeley Kevin (CHIEF FINANCIAL OFFICER) sold 1,285 shares at $84.22 on 9 September 2026, $108,220https://greeksoup.ai/stocks/us/wgs/insiders/us:WGS:insider:2026-09-11:d5b3189e2cFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Feeley Kevin (CHIEF FINANCIAL OFFICER) sold 372 shares at $83.84 on 1 September 2026, $31,188https://greeksoup.ai/stocks/us/wgs/insiders/us:WGS:insider:2026-09-03:6de63fcb52Thu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Form 144, Kevin Feeley plans to sell 5,410 shares worth $458,500 around 1 September 2026https://greeksoup.ai/stocks/us/wgs/planned-sales/us:WGS:planned-sale:2026-09-01:b6ac39d564Tue, 01 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Form 144, Katherine Stueland plans to sell 14,243 shares worth $1.2 million around 9 September 2026https://greeksoup.ai/stocks/us/wgs/planned-sales/us:WGS:planned-sale:2026-09-01:fcb663593eTue, 01 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: short interest 6,001,270 shares at the 31 August 2026 settlement, 12.43 days to coverhttps://greeksoup.ai/stocks/us/wgs/short-interest/us:WGS:short-interest:2026-08-31:625c054921Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: short interest 6,289,158 shares at the 14 August 2026 settlement, 6.39 days to coverhttps://greeksoup.ai/stocks/us/wgs/short-interest/us:WGS:short-interest:2026-08-14:ff31130f5fFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Schedule 13G filed by THE GOLDMAN SACHS GROUP, INC., 5.8% of the classhttps://greeksoup.ai/stocks/us/wgs/holders/us:WGS:schedule-13:2026-08-11:68ed110552Tue, 11 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: Schedule 13G/A filed by ARK Investment Management LLC, 5.3% of the classhttps://greeksoup.ai/stocks/us/wgs/holders/us:WGS:schedule-13:2026-08-07:34adcaa987Fri, 07 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp. Q2 FY2026 results: revenue $114 million, net income -$18 millionhttps://greeksoup.ai/stocks/us/wgs/results/fy2026-q2/us:WGS:result:2026-08-03:44ab465c01Mon, 03 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/wgs/filings/us:WGS:filing:2026-08-03:904019556aMon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/wgs/filings/us:WGS:filing:2026-08-03:2be1468af9Mon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> GeneDx Holdings Corp.: short interest 5,848,506 shares at the 31 July 2026 settlement, 8.58 days to coverhttps://greeksoup.ai/stocks/us/wgs/short-interest/us:WGS:short-interest:2026-07-31:a8fc30a8d9Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>